By Stanley Onyekwere
The Sickle Cell Support Society of Nigeria (SCSSN), in conjunction with Silver Lake Research Corporation Asuza California gathered stakeholders and dissected Hemo TypeSC , a novel point of care test for the detection of sickle cell disease.
Presenting a lecture titled “New born screening” , in Abuja, the vice-chairman of Sickle Cell Support Society of Nigeria, Prof. Obiageli Nnodu said the Society had trained health workers in some medical centres with a view to empowering them to have a requisite knowledge of detecting sickle cell disorder.
Nnodu, who is also the Director Centre for Sickle Cell Research and Training (CESTRA), reiterated that the society would continue to provide infrastructure in the health centres in order to reduce the burden of sickle cell disease in the communities.
The professor of Hematology and Blood Transfusion College of Health Sciences, University of Abuja touched on the national guidelines for the control and management of sickle cell disease as well as the procedure to implement the new born screening.
He noted that the society would continue to stage sickle cell advocacy campaign with a view to educating members of the public, just as she commended the World Health Organisation, WHO, for working closely with the society.
Also contributing, Mr. Eric Serrao of the Silver Lake Corporation Study, Asuza California revealed that not less than 700 to 500 both adults and new born respectively have been screened through Hemo TypeSC, aimed at reducing the burden of sickle cell disease.